Hamps Bio Ltd is engaged in ethical marketing and distribution of pharmaceutical formulation products. The company distributes various products, such as tablets, capsules, oil, gel, syrups, powders, and nutrition supplements. In 2017, it launched Freeze Dried and Frozen Products (FDFP) Division wherein the company manufactures FDFP products at its manufacturing facility in Gujarat. Currently, its product portfolio has 180+ products. It also sells products on e-commerce platforms, including Amazon.om, Amazon.ca, Amazon.eu, Flipkart, Jio Mart, etc. Its products are majorly sold in 8 states and Union territories and fFDFP are sold in 6 countries, and 22 states and UT.
Hamps Bio IPO open date is December 13, 2024 and the IPO will close on December 17, 2024. Hamps Bio IPO is a Fixed Price Issue. Hamps Bio IPO price band is ₹51 per share. The retail quota is 50%, QIB is 00%, and HNI is 50%. Hamps Bio IPO to list on BSE on December 20, 2024. The allotment of Hamps Bio IPO date is December 18, 2024. The company reported Profit of ₹0.50 crores in 2024 against Profit of ₹0.36 crores in 2023.
Hamps Bio IPO Details
| IPO Open Date: | December 13, 2024 |
| IPO Close Date: | December 17, 2024 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹51 Per Share |
| Issue Size: | Approx ₹6.22 Crores |
| Fresh Issue: | Approx ₹6.22 Crores |
| IPO Listing: | BSE SME |
| Retail Quota: | Not more than 50% |
| QIB Quota: | Not more than 00% |
| NII Quota: | Not more than 50% |
Hamps Bio IPO Timeline
The Hamps Bio IPO date is December 13 and the close date is December 17. The Hamps Bio IPO allotment will be finalized on December 18 and the IPO listing on December 20.
| IPO Open Date: | December 13, 2024 |
| IPO Close Date: | December 17, 2024 |
| Basis of Allotment: | December 18, 2024 |
| Refunds: | December 19, 2024 |
| Credit to Demat Account: | December 19, 2024 |
| IPO Listing Date: | December 20, 2024 |
Hamps Bio SME IPO Lots
| SME IPO Activity | Date |
|---|---|
| Issue Price | ₹51.00 |
| Market Lot: | 2000 Shares |
| 1 Lot Amount: | ₹102000 |
| Min HNI Lots: | 4000 shares (2 lots)- ₹204000 |
Hamps Bio Limited: Financial Highlights and Analysis
Hamps Bio Limited’s revenue increased by 16.41% and profit after tax (PAT) rose by 39.47% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 31 Oct 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 644.00 | 514.77 | 395.87 | 364.31 |
| Revenue | 436.42 | 650.13 | 558.49 | 534.46 |
| Profit After Tax | 34.08 | 50.07 | 35.90 | 12.15 |
| Net Worth | 370.78 | 337.42 | 136.30 | 100.57 |
| Reserves and Surplus | 57.18 | 141.42 | -13.70 | -49.43 |
| Total Borrowing | 138.31 | 104.52 | 173.77 | 204.31 |
